3D-printed tumors potentially next step in personalized medicine

Scientists at Tel Aviv University in Israel have successfully printed an entire active and viable brain tumor for the first time, using a three-dimensional (or 3D) printer. The researchers recreated the flowing blood vessels and surrounding brain tissue. Study: Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Image Credit: peterschreiber.media/ Shutterstock Published in the peer-reviewed journal […]

Read more

Study improves understanding of how formal volunteering influences health and well-being

Formal volunteering in later life is beneficial for both physical and psychological well-being. However, research has shown that older adults with key advantages, such as wealth, are more likely to volunteer and reap its benefits. In a new study appearing in the American Journal of Preventive Medicine, published by Elsevier, investigators found that lower-wealth volunteers may experience even greater health […]

Read more

SwabSeq platform offers a potential solution for massive COVID-19 testing

In an article appearing in Nature Biomedical Engineering, a team of scientists from the UCLA David Geffen School of Medicine and UCLA School of Engineering report real-world results on SwabSeq, a high-throughput testing platform that uses sequencing to test thousands of samples at a time to detect COVID-19. They were able to perform more than 80,000 tests in less than […]

Read more

New resource could make targeted cancer therapies more accessible for Australian patients

A new resource developed at the Garvan Institute of Medical Research and The Kinghorn Cancer Centre for oncologists could help make targeted cancer therapies more accessible for Australian patients. The TOPOGRAPH (Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer Pharmaceuticals) database is an online tool that catalogues oncology research to streamline the process of recommending therapeutic treatments in precision cancer medicine. […]

Read more

Insilico Medicine receives $255 million to develop AI and drug discovery capabilities

Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine's current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities. It also […]

Read more

F.D.A. Announces Plan to Ban Menthol Cigarettes and Flavored Cigars

The Food and Drug Administration on Thursday announced its long-awaited plan to ban the last flavor still allowed in cigarettes — menthol — and also said it would ban all flavors of mass-produced cigars, which are popular among youths. The ban would apply only to sales, manufacturing and imports — not personal possession. “Together, these actions represent powerful, science-based approaches […]

Read more

F.D.A. Announces Plan to Ban Menthol Cigarettes and Flavored Cigars

The Food and Drug Administration on Thursday announced its long-awaited plan to ban the last flavor still allowed in cigarettes — menthol — and also said it would ban all flavors of mass-produced cigars, which are popular among youths. The ban would apply only to sales, manufacturing and imports — not personal possession. “Together, these actions represent powerful, science-based approaches […]

Read more

Study in Ireland identifies underlying conditions associated with severe COVID-19 outcomes

A national study of 20,000 patients conducted by RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) has identified the underlying conditions that are associated with more severe outcomes from COVID-19 in an Irish setting.   The research, which has been published in The Lancet Regional Health – Europe, will help inform national public […]

Read more

Immune tolerance in hemophilia can be modulated by B cell activating factor

A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A. Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII). […]

Read more

Study shows decline in subarachnoid hemorrhage hospitalizations during COVID-19 pandemic

New research led by investigators from Boston Medical Center and Grady Memorial Hospital demonstrates the significant decline in hospitalizations for neurological emergencies during the COVID-19 pandemic. The rate of Subarachnoid hemorrhage (SAH) – bleeding in the space between the brain and the tissue covering the brain – hospitalizations declined 22.5 percent during the study period, which is consistent with the […]

Read more
1 2 3 11